Angus C. Russell is Director of TherapeuticsMD, Inc.. Currently has a direct ownership of 5,792 shares of TXMD, which is worth approximately $6,429. The most recent transaction as insider was on Aug 18, 2022, when has been sold 1,984 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.79K
0% 3M change
0% 12M change
Total Value Held $6,429

Angus C. Russell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 18 2022
BUY
Exercise of conversion of derivative security
-
1,984 Added 25.51%
5,792 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
-
96,864 Added 33.72%
190,364 Common Stock

Also insider at

MNKPF
Mallinckrodt plc Healthcare
RVNC
Revance Therapeutics, Inc. Healthcare
LCTX
Lineage Cell Therapeutics, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
ACR

Angus C. Russell

Director
Carlsbad, CA

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Track Activities on TXMD